Abstract
Radiotherapy can be safely delivered during the coronavirus disease 2019 (COVID-19) pandemic, often through use of hypofractionated regimens, which minimize the number of visits to treatment centres while also avoiding potentially detrimental delays in the delivery of cancer care.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Breast Neoplasms / complications
-
Breast Neoplasms / radiotherapy*
-
Breast Neoplasms / virology
-
COVID-19
-
Coronavirus Infections / complications
-
Coronavirus Infections / radiotherapy*
-
Coronavirus Infections / virology
-
Disease-Free Survival
-
Female
-
Head and Neck Neoplasms / complications
-
Head and Neck Neoplasms / radiotherapy*
-
Head and Neck Neoplasms / virology
-
Humans
-
Lung Neoplasms / complications
-
Lung Neoplasms / radiotherapy*
-
Lung Neoplasms / virology
-
Pandemics
-
Pneumonia, Viral / complications
-
Pneumonia, Viral / radiotherapy*
-
Pneumonia, Viral / virology